United Kingdom
Medical Technologies Sector Review
Definition and scale of sector
- Polymer/metal components,
- Electronics/electromechanical sub assemblies,
- Medical instrumentation,
- Pharmaceutical production, wholesaling
Sub Menu
Top of page 
Back on Track - The European Perspective - December 2006
Europe's biotech industry is decisively back on track. After years of consolidation and relatively stagnant results, the industry's performance was markedly better on several fronts - from strong initial public offerings (IPOs) to significantly stronger financial performance.
The focus on consolidation and restructuring, while lengthy and painful, finally paid dividends in 2005. Fueled by a stronger pipeline as well as higher number of companies with revenues, top-line growth accelerated significantly.
Source: Ernst and Young
FOR THE FULL REPORT PLEASE CLICK HERE
Beyond Borders - A Global Perspective - December 2006
As the modern biotechnology industry turns 30, biotech companies are leveraging resources and competitive strengths to fill critical gaps and meet strategic needs. The sector is bringing together the various worlds we inhabit - the developing world and the developed world, the worlds of research and of commercial development, the world of science and the world of finance - to give us the vibrant, global biotechnology industry of today.
Source: Ernst and Young
FOR THE FULL REPORT PLEASE CLICK HERE
Medical Technologies Cluster Strategy 2006-2008
This new strategy has been developed by the Medical Technologies Cluster Opportunity Group using evidence from the recently completed cluster research project and in consultation with representatives from industry, healthcare providers and other key partners.
The COG acts as an advisory body to Advantage West Midlands and is responsible for overseeing the development and implementation of the cluster strategy. Its membership includes representatives from both the public sector and industry.
Source: The Cluster Opportunity Group (COG)
FOR THE FULL REPORT PLEASE CLICK
The Ernst and Young UK Medical Products Industry Monitor - June 2006
The period 2000-2006 has been one of the most fascinating for anyone working in the healthcare industry. The NHS has been told to increase throughput, patients have been told to be customers, employers have been put thorough the Agenda for Change, and healthcare priorities have been reconfigured.
In lights of all this, generally there appears to be something of a cautious optimism amongst UK medical product companies. A sense that things can only get better is coupled with a significant level of uncertainty about the current and future state of the industry.
Source: Ernst and Young
FOR THE FULL REPORT PLEASE CLICK HERE
West Midlands Priority Clusters Internationalisation Programme - Medical Technologies Cluster - Business Plan for 2006/07
In the spirit of what has now become the formally agreed dual key approach to the provision of international trade and investment services, UKTI agreed with AWM a £4.5 million, three year programme to add an international dimension to the work being undertaken in the ten priority clusters.
The programme allowed strengthening of the six sub -regional UKTI international trade teams based at Chamber/Business Links with the balance of the monies being devoted to programmes to help the companies in the clusters to improve their international trading performance through direct exports or through some form of overseas investment, including everything from technology licensing to new plants.
Source: Advantages West Midlands
FOR THE FULL REPORT PLEASE CLICK HERE
Top of page | 
